2024 Q1 Form 10-K Financial Statement

#000076889924000043 Filed on February 21, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $402.9M $492.2M $1.906B
YoY Change -13.42% -11.75% -15.44%
Cost Of Revenue $303.5M $363.9M $1.400B
YoY Change -11.31% -11.21% -15.25%
Gross Profit $99.39M $128.3M $506.1M
YoY Change -19.27% -13.23% -15.96%
Gross Profit Margin 24.67% 26.06% 26.55%
Selling, General & Admin $106.9M $132.9M $494.6M
YoY Change -12.81% -0.65% -1.21%
% of Gross Profit 107.6% 103.57% 97.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.958M $6.946M $25.82M
YoY Change 24.13% -4.3% -11.79%
% of Gross Profit 8.01% 5.41% 5.1%
Operating Expenses $106.9M $139.8M $494.6M
YoY Change -12.81% -0.84% -6.67%
Operating Profit -$15.51M -$11.53M -$23.85M
YoY Change 160.96% -268.07% -133.04%
Interest Expense -$820.0K $4.124M $7.588M
YoY Change -237.35% 3000.75% 516.41%
% of Operating Profit
Other Income/Expense, Net $1.599M
YoY Change 57.69%
Pretax Income -$13.91M -$7.402M -$20.65M
YoY Change 182.21% -205.88% -128.12%
Income Tax -$12.21M -$4.851M -$6.472M
% Of Pretax Income
Net Earnings -$1.698M -$2.551M -$14.17M
YoY Change -60.41% -136.21% -122.76%
Net Earnings / Revenue -0.42% -0.52% -0.74%
Basic Earnings Per Share -$0.05 -$0.45
Diluted Earnings Per Share -$0.05 -$0.08 -$0.45
COMMON SHARES
Basic Shares Outstanding 31.39M shares 31.14M shares 31.32M shares
Diluted Shares Outstanding 31.10M shares 31.32M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.18M $61.89M $61.89M
YoY Change -23.38% -14.11% -14.11%
Cash & Equivalents $36.18M $61.89M $61.89M
Short-Term Investments
Other Short-Term Assets $5.617M $6.259M $28.89M
YoY Change -35.55% -85.74% -34.16%
Inventory
Prepaid Expenses
Receivables $244.2M $252.5M $252.5M
Other Receivables $10.06M $11.68M $11.68M
Total Short-Term Assets $315.4M $355.0M $355.0M
YoY Change -15.05% -17.48% -17.48%
LONG-TERM ASSETS
Property, Plant & Equipment $104.4M $104.9M $154.7M
YoY Change 6.61% 9.48% 61.47%
Goodwill $83.87M $84.11M
YoY Change -10.56% -10.31%
Intangibles $8.995M $10.53M
YoY Change -39.87% -35.05%
Long-Term Investments
YoY Change
Other Assets $14.52M $12.74M $241.2M
YoY Change -15.37% -96.68% -37.09%
Total Long-Term Assets $553.2M $544.4M $544.4M
YoY Change -5.57% -7.6% -7.6%
TOTAL ASSETS
Total Short-Term Assets $315.4M $355.0M $355.0M
Total Long-Term Assets $553.2M $544.4M $544.4M
Total Assets $868.6M $899.4M $899.4M
YoY Change -9.25% -11.77% -11.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.62M $56.40M $56.40M
YoY Change -31.8% -26.41% -26.41%
Accrued Expenses $134.2M $92.02M $92.02M
YoY Change -3.77% -0.23% -0.23%
Deferred Revenue $1.844M
YoY Change -51.63%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $44.87M $44.87M
YoY Change -10.28% -10.28%
Total Short-Term Liabilities $184.0M $204.1M $204.1M
YoY Change -14.4% -15.97% -15.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $35.21M $35.21M
YoY Change 34.3% 34.3%
Other Long-Term Liabilities $4.763M $1.123M $202.2M
YoY Change 137.56% -99.6% -27.84%
Total Long-Term Liabilities $4.763M $1.123M $237.4M
YoY Change 137.56% -99.6% -15.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $184.0M $204.1M $204.1M
Total Long-Term Liabilities $4.763M $1.123M $237.4M
Total Liabilities $422.2M $441.5M $441.5M
YoY Change -13.74% -15.6% -15.6%
SHAREHOLDERS EQUITY
Retained Earnings $467.1M $478.6M
YoY Change -4.26% -7.31%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $446.4M $457.9M $457.9M
YoY Change
Total Liabilities & Shareholders Equity $868.6M $899.4M $899.4M
YoY Change -9.25% -11.77% -11.77%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.698M -$2.551M -$14.17M
YoY Change -60.41% -136.21% -122.76%
Depreciation, Depletion And Amortization $7.958M $6.946M $25.82M
YoY Change 24.13% -4.3% -11.79%
Cash From Operating Activities -$14.24M $14.89M $34.75M
YoY Change -255.6% -63.18% -71.16%
INVESTING ACTIVITIES
Capital Expenditures $7.375M $8.181M $31.28M
YoY Change -8.74% -203.02% -202.12%
Acquisitions
YoY Change
Other Investing Activities $8.294M $2.415M $0.00
YoY Change -2911.53% -126.64% -100.0%
Cash From Investing Activities $919.0K -$5.766M -$32.32M
YoY Change -110.97% -66.1% 54.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $34.18M
YoY Change -153.04%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$13.66M -254.0K -$37.58M
YoY Change -49.07% -1594.12% -41.9%
NET CHANGE
Cash From Operating Activities -$14.24M 14.89M $34.75M
Cash From Investing Activities $919.0K -5.766M -$32.32M
Cash From Financing Activities -$13.66M -254.0K -$37.58M
Net Change In Cash -$27.59M 8.865M -$36.33M
YoY Change 5.93% -62.18% -204.18%
FREE CASH FLOW
Cash From Operating Activities -$14.24M $14.89M $34.75M
Capital Expenditures $7.375M $8.181M $31.28M
Free Cash Flow -$21.61M $6.704M $3.478M
YoY Change -2120.0% -86.14% -97.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000768899
CY2023 us-gaap Impairment Of Intangible Asset Indefinite Lived Excluding Goodwill Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetIndefiniteLivedExcludingGoodwillStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#GoodwillAndIntangibleAssetImpairment
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-14543
CY2023 dei Entity Registrant Name
EntityRegistrantName
TrueBlue, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1287341
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1015 A Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Tacoma
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98402
CY2023 dei City Area Code
CityAreaCode
253
CY2023 dei Local Phone Number
LocalPhoneNumber
383-9101
CY2023 dei Security12b Title
Security12bTitle
Common stock, no par value
CY2023 dei Trading Symbol
TradingSymbol
TBI
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
500000000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31387635 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72054000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2005000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3212000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
252538000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
314275000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28894000 usd
CY2023 dei Auditor Name
AuditorName
Deloitte & Touche, LLP
CY2023 dei Auditor Location
AuditorLocation
Seattle, Washington
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61885000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32530000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11676000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
11353000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
354993000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
430212000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104906000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95823000 usd
CY2023Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
192985000 usd
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
213734000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35465000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25842000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
84114000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
93784000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10525000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16205000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49819000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50823000 usd
CY2023Q4 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
53841000 usd
CY2022Q4 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
75185000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12735000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17800000 usd
CY2023Q4 us-gaap Assets
Assets
899383000 usd
CY2022Q4 us-gaap Assets
Assets
1019408000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
56401000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
76644000 usd
CY2023Q4 tbi Accrued Salaries And Employee Benefits Current
AccruedSalariesAndEmployeeBenefitsCurrent
80120000 usd
CY2022Q4 tbi Accrued Salaries And Employee Benefits Current
AccruedSalariesAndEmployeeBenefitsCurrent
92237000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
439000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1137000 usd
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
44866000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
50005000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11902000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11963000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10371000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10889000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
204099000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
242875000 usd
CY2023Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
151649000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
201005000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
35205000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
26213000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
49434000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50601000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1123000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2399000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
441510000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
523093000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.131
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.131
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31245732 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31245732 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32729689 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32729689 shares
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20712000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20018000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
478584000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
516332000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
457873000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
496315000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
899383000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1019408000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1906243000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2254184000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2173622000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1400184000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1652040000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1613302000 usd
CY2023 us-gaap Gross Profit
GrossProfit
506059000 usd
CY2022 us-gaap Gross Profit
GrossProfit
602144000 usd
CY2021 us-gaap Gross Profit
GrossProfit
560320000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
494603000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
500686000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
464322000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25821000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29273000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27556000 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9485000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-23850000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
72185000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
68442000 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
3205000 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
1231000 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
5408000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73850000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.86
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31317000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32889000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34798000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31317000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33447000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35434000 shares
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-694000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4271000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-919000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-694000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4271000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-919000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14867000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58002000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
60715000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
437190000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
61634000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-919000 usd
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
16678000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2103000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13943000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
493067000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
62273000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4271000 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
60939000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3502000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9687000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
496315000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14173000 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-694000 usd
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
34178000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3304000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13907000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
457873000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14173000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
62273000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
61634000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25821000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29273000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27556000 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9485000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4972000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4462000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6493000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
13907000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
9687000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
13943000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9902000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3933000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
752000 usd
CY2023 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
12591000 usd
CY2022 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
12920000 usd
CY2021 tbi Lease Cost Noncash Expense
LeaseCostNoncashExpense
14446000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3831000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7862000 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1968000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-56761000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34765000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
81616000 usd
CY2023 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1317000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2665000 usd
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1602000 usd
CY2023 us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
0 usd
CY2022 us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-118000 usd
CY2021 us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-8080000 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-31366000 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16142000 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
13715000 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-19210000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1501000 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
16425000 usd
CY2023 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-12113000 usd
CY2022 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-7938000 usd
CY2021 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
34581000 usd
CY2023 tbi Increase Decrease In Employer Payroll Tax Liabilities
IncreaseDecreaseInEmployerPayrollTaxLiabilities
0 usd
CY2022 tbi Increase Decrease In Employer Payroll Tax Liabilities
IncreaseDecreaseInEmployerPayrollTaxLiabilities
0 usd
CY2021 tbi Increase Decrease In Employer Payroll Tax Liabilities
IncreaseDecreaseInEmployerPayrollTaxLiabilities
-57065000 usd
CY2023 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-54495000 usd
CY2022 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-5184000 usd
CY2021 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
701000 usd
CY2023 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-12796000 usd
CY2022 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-13052000 usd
CY2021 tbi Increase Decreasein Operating Leases Liabilities
IncreaseDecreaseinOperatingLeasesLiabilities
-13457000 usd
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7688000 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1692000 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2048000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34754000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
120503000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20440000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31276000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30626000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35006000 usd
CY2023 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
2347000 usd
CY2022 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 usd
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
4000000 usd
CY2023 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1662000 usd
CY2022 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0 usd
CY2021 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
832000 usd
CY2023 tbi Payments To Acquire Restricted Investments Availableforsale Investments
PaymentsToAcquireRestrictedInvestmentsAvailableforsaleInvestments
0 usd
CY2022 tbi Payments To Acquire Restricted Investments Availableforsale Investments
PaymentsToAcquireRestrictedInvestmentsAvailableforsaleInvestments
0 usd
CY2021 tbi Payments To Acquire Restricted Investments Availableforsale Investments
PaymentsToAcquireRestrictedInvestmentsAvailableforsaleInvestments
43000 usd
CY2023 tbi Proceeds From Saleand Maturity Of Restricted Investments Availablefor Sale
ProceedsFromSaleandMaturityOfRestrictedInvestmentsAvailableforSale
0 usd
CY2022 tbi Proceeds From Saleand Maturity Of Restricted Investments Availablefor Sale
ProceedsFromSaleandMaturityOfRestrictedInvestmentsAvailableforSale
0 usd
CY2021 tbi Proceeds From Saleand Maturity Of Restricted Investments Availablefor Sale
ProceedsFromSaleandMaturityOfRestrictedInvestmentsAvailableforSale
7333000 usd
CY2023 tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
34110000 usd
CY2022 tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
18031000 usd
CY2021 tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
9411000 usd
CY2023 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
33749000 usd
CY2022 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
27712000 usd
CY2021 tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
23935000 usd
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-140000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32322000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20945000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16220000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34178000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
60939000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16678000 usd
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
856000 usd
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
980000 usd
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1135000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4161000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4480000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3238000 usd
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-100000 usd
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-253000 usd
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-345000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37583000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64692000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19126000 usd
CY2023 tbi Change In Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reclassified To Assets Held For Sale
ChangeInCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReclassifiedToAssetsHeldForSale
300000 usd
CY2022 tbi Change In Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reclassified To Assets Held For Sale
ChangeInCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReclassifiedToAssetsHeldForSale
0 usd
CY2021 tbi Change In Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Reclassified To Assets Held For Sale
ChangeInCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsReclassifiedToAssetsHeldForSale
0 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-874000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2420000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-521000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36325000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32446000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15427000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135631000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103185000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118612000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99306000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135631000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103185000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1031000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1123000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1425000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5171000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9980000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9773000 usd
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15799000 usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15964000 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
16590000 usd
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3404000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4502000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3949000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12526000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9637000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11878000 usd
CY2023 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt;text-align:justify"><span style="color:#006ebf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal period end</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements are presented on a 52/53-week fiscal year-end basis, with the last day of the fiscal year ending on the Sunday closest to the last day of December. In fiscal years consisting of 53 weeks, the final quarter consists of 14 weeks, while in fiscal years consisting of 52 weeks, all quarters consist of 13 weeks. Our 2023 fiscal year contained 53 weeks, with the 53rd week falling in the fiscal fourth quarter, while our 2022 and 2021 fiscal years contained 52 weeks.</span></div>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify"><span style="color:#006ebf;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Estimates in our financial statements include, but are not limited to, acquisition method of accounting, allowance for credit losses, estimates for asset and goodwill impairments, stock-based awards, assumptions underlying self-insurance reserves, contingent legal, regulatory and government incentive liabilities, and the potential outcome of future tax consequences of events that have been recognized in the financial statements. Actual results and outcomes may differ from these estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment.</span></div>
CY2023 us-gaap Advertising Expense
AdvertisingExpense
9200000 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
12500000 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
9700000 usd
CY2023Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P15Y
CY2023Q4 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.20
CY2023Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
23598000 usd
CY2022Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
29567000 usd
CY2023Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
12703000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
30857000 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
122659000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123678000 usd
CY2023Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
32905000 usd
CY2022Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
26479000 usd
CY2023Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
1120000 usd
CY2022Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
3153000 usd
CY2023Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
192985000 usd
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
213734000 usd
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
122659000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
533000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2279000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120913000 usd
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
123678000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
6000 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
4159000 usd
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
119525000 usd
CY2023 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1700000 usd
CY2023 tbi Proceeds From Life Insurance Policy Amount In Excess Of Cash Surrender Value
ProceedsFromLifeInsurancePolicyAmountInExcessOfCashSurrenderValue
1400000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
4383000 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-5841000 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1061000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
280185000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
184523000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3212000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6687000 usd
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2921000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4972000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4462000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6493000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6184000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
7917000 usd
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2713000 usd
CY2023 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
5000 usd
CY2022 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
-20000 usd
CY2021 us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
-14000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2005000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3212000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6687000 usd
CY2023Q4 tbi Prepaid Software Agreements
PrepaidSoftwareAgreements
8435000 usd
CY2022Q4 tbi Prepaid Software Agreements
PrepaidSoftwareAgreements
9994000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9355000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9455000 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current Other
AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
4845000 usd
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current Other
AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
0 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6259000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13081000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28894000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32530000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1844000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3812000 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
1998000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
0 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6529000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7077000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10371000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
10889000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
289429000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
184362000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104906000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
95823000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
73300000 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
28100000 usd
CY2023 us-gaap Depreciation Nonproduction
DepreciationNonproduction
20600000 usd
CY2022 us-gaap Depreciation Nonproduction
DepreciationNonproduction
23500000 usd
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
20900000 usd
CY2021Q4 us-gaap Goodwill Gross
GoodwillGross
330106000 usd
CY2021Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
235568000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
94538000 usd
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-754000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
329352000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
235568000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
93784000 usd
CY2023 tbi Goodwill Reclassification To Held For Sale
GoodwillReclassificationToHeldForSale
1020000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8885000 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
235000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
328567000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
244453000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
84114000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
95923000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
90798000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5125000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
95703000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
85498000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10205000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5200000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5700000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6700000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4049000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
309000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
118000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
118000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
118000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
413000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5125000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
5400000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
6000000 usd
tbi Workers Compensation Claim Deductible Limit
WorkersCompensationClaimDeductibleLimit
5000000 usd
CY2023 tbi Weighted Average Period Claim Payments Below Deductible Limit
WeightedAveragePeriodClaimPaymentsBelowDeductibleLimit
P5Y6M
CY2023Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
214611000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
270468000 usd
CY2023Q4 tbi Workers Compensation Discount Reserve Amount
WorkersCompensationDiscountReserveAmount
18096000 usd
CY2022Q4 tbi Workers Compensation Discount Reserve Amount
WorkersCompensationDiscountReserveAmount
19458000 usd
CY2023Q4 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
196515000 usd
CY2022Q4 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
251010000 usd
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
44866000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
50005000 usd
CY2023Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
151649000 usd
CY2022Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
201005000 usd
CY2023 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
45000000 usd
CY2022 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
39400000 usd
CY2021 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
41900000 usd
CY2023 tbi Weighted Average Period Claim Payments And Receivables Above Deductible Limit
WeightedAveragePeriodClaimPaymentsAndReceivablesAboveDeductibleLimit
P18Y
CY2023Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
54900000 usd
CY2022Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
76700000 usd
CY2023Q4 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
53800000 usd
CY2022Q4 tbi Workers Compensation Claim Receivables Net Of Valuation Allowance
WorkersCompensationClaimReceivablesNetOfValuationAllowance
75200000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments Next Twelve Months
ExpectedFutureWorkersCompensationPaymentsNextTwelveMonths
44866000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments Year Two
ExpectedFutureWorkersCompensationPaymentsYearTwo
23494000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments Year Three
ExpectedFutureWorkersCompensationPaymentsYearThree
13764000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments Year Four
ExpectedFutureWorkersCompensationPaymentsYearFour
9193000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments Year Five
ExpectedFutureWorkersCompensationPaymentsYearFive
6705000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments After Year Five
ExpectedFutureWorkersCompensationPaymentsAfterYearFive
43566000 usd
CY2023Q4 tbi Workers Compensation Liability Excluding Excess Claims Reserve
WorkersCompensationLiabilityExcludingExcessClaimsReserve
141588000 usd
CY2023Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
54927000 usd
CY2023Q4 tbi Expected Future Workers Compensation Payments
ExpectedFutureWorkersCompensationPayments
196515000 usd
CY2023 tbi Workers Compensation Expense
WorkersCompensationExpense
20100000 usd
CY2022 tbi Workers Compensation Expense
WorkersCompensationExpense
29800000 usd
CY2021 tbi Workers Compensation Expense
WorkersCompensationExpense
39800000 usd
CY2023Q4 tbi Debt Instrument Leverage Ratio Threshold
DebtInstrumentLeverageRatioThreshold
3.00
CY2023Q4 tbi Debt Instrument Leverage Ratio
DebtInstrumentLeverageRatio
0.20
CY2023Q4 tbi Debt Instrument Fixed Charge Coverage Ratio
DebtInstrumentFixedChargeCoverageRatio
15.16
CY2023Q4 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
17737000 usd
CY2022Q4 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
23716000 usd
CY2023Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
12703000 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
30857000 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
122659000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
123678000 usd
CY2023Q4 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2022Q4 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2023Q4 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20725000 usd
CY2022Q4 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20806000 usd
CY2023Q4 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
179901000 usd
CY2022Q4 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
205134000 usd
CY2023 tbi Collateral Commitments Surety Bond Annual Fee Limit Percentage Of Bond Amount
CollateralCommitmentsSuretyBondAnnualFeeLimitPercentageOfBondAmount
0.020
CY2023Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P13Y
CY2023Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
14710000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
14994000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
6915000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
7487000 usd
CY2023 tbi Operating Lease Cost.Other
OperatingLeaseCost.Other
3748000 usd
CY2022 tbi Operating Lease Cost.Other
OperatingLeaseCost.Other
4501000 usd
CY2023 us-gaap Lease Cost
LeaseCost
25373000 usd
CY2022 us-gaap Lease Cost
LeaseCost
26982000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
14961000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12465000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9639000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7558000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5882000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
24589000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
75094000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12578000 usd
CY2023Q4 tbi Present Value Of Operating Lease Liability Held For Sale
PresentValueOfOperatingLeaseLiabilityHeldForSale
1180000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
61336000 usd
CY2023Q4 tbi Lessee Operating Lease Liability Pending
LesseeOperatingLeaseLiabilityPending
200000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
37400000 usd
CY2023Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
17700000 usd
CY2023Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
16100000 usd
CY2023Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
3600000 usd
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1877000 shares
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2234000 shares
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
620000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2023 tbi Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Common Stock Shares Representedby Each Performance Share
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofCommonStockSharesRepresentedbyEachPerformanceShare
1 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1436000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
21.93
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1137000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.77
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
761000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
20.70
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
236000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
19.59
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1576000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.88
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
17.77
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.51
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.21
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13900000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9700000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13900000 usd
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2900000 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2000000 usd
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2900000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
41000000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
31300000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
5800000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
5100000 usd
CY2023 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
4100000 usd
CY2022 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
5100000 usd
CY2021 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
6500000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
329000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1360000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4925000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
582000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1397000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4067000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2817000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4635000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2393000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3728000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
7392000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11385000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-8109000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3434000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
617000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1383000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
345000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
88000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-708000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-28000 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
126000 usd
CY2023 tbi Deferred Income Tax Expense Benefit Inclusive Of Previously Reported Items
DeferredIncomeTaxExpenseBenefitInclusiveOfPreviouslyReportedItems
-10200000 usd
CY2022 tbi Deferred Income Tax Expense Benefit Inclusive Of Previously Reported Items
DeferredIncomeTaxExpenseBenefitInclusiveOfPreviouslyReportedItems
3751000 usd
CY2021 tbi Deferred Income Tax Expense Benefit Inclusive Of Previously Reported Items
DeferredIncomeTaxExpenseBenefitInclusiveOfPreviouslyReportedItems
831000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6472000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11143000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12216000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4335000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
15417000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
15508000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1384000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.067
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3008000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.041
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3548000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
4997000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.242
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
7911000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.108
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
7582000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.103
CY2023 tbi Effective Income Tax Rate Reconciliation Cares Act Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationCARESActTaxBenefitAmount
0 usd
CY2023 tbi Effective Income Tax Rate Reconciliation Cares Act Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationCARESActTaxBenefitPercent
0
CY2022 tbi Effective Income Tax Rate Reconciliation Cares Act Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationCARESActTaxBenefitAmount
0 usd
CY2022 tbi Effective Income Tax Rate Reconciliation Cares Act Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationCARESActTaxBenefitPercent
0
CY2021 tbi Effective Income Tax Rate Reconciliation Cares Act Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationCARESActTaxBenefitAmount
468000 usd
CY2021 tbi Effective Income Tax Rate Reconciliation Cares Act Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationCARESActTaxBenefitPercent
0.006
CY2023 tbi Effective Income Tax Rate Reconciliation Uncertain Tax Positions Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsTaxBenefitAmount
206000 usd
CY2023 tbi Effective Income Tax Rate Reconciliation Uncertain Tax Positions Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsTaxBenefitPercent
-0.010
CY2022 tbi Effective Income Tax Rate Reconciliation Uncertain Tax Positions Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsTaxBenefitAmount
1336000 usd
CY2022 tbi Effective Income Tax Rate Reconciliation Uncertain Tax Positions Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsTaxBenefitPercent
0.018
CY2021 tbi Effective Income Tax Rate Reconciliation Uncertain Tax Positions Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsTaxBenefitAmount
391000 usd
CY2021 tbi Effective Income Tax Rate Reconciliation Uncertain Tax Positions Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsTaxBenefitPercent
0.005
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
2287000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
-0.111
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1178000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.057
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1377000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.019
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
589000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.008
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
587000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.029
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
654000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.009
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
211000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.003
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
398000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.019
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-66000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
801000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6472000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.313
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11143000 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.152
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12216000 usd
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.165
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.313
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9500000 usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8900000 usd
CY2023 tbi Effective Income Tax Rate Reconciliation Deductible Expense Impairment Losses Amount
EffectiveIncomeTaxRateReconciliationDeductibleExpenseImpairmentLossesAmount
2300000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-27773000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
56964000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
61433000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
7128000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
16452000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
12417000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20645000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73416000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73850000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
590000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
869000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
11242000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
9641000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7535000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1243000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
16030000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
9801000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
7311000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
8877000 usd
CY2023Q4 tbi Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Deferred Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDeferredCompensation
12356000 usd
CY2022Q4 tbi Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Deferred Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsDeferredCompensation
8641000 usd
CY2023Q4 tbi Deferred Tax Assets Leasing Liabilities
DeferredTaxAssetsLeasingLiabilities
17378000 usd
CY2022Q4 tbi Deferred Tax Assets Leasing Liabilities
DeferredTaxAssetsLeasingLiabilities
16025000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
371000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
368000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
72813000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
55465000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
834000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2152000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
71979000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
53313000 usd
CY2023Q4 tbi Deferred Tax Liabilities Prepaid Expenses Deposits And Other Current Assets
DeferredTaxLiabilitiesPrepaidExpensesDepositsAndOtherCurrentAssets
655000 usd
CY2022Q4 tbi Deferred Tax Liabilities Prepaid Expenses Deposits And Other Current Assets
DeferredTaxLiabilitiesPrepaidExpensesDepositsAndOtherCurrentAssets
583000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
14052000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
12909000 usd
CY2023Q4 tbi Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
21958000 usd
CY2022Q4 tbi Deferred Tax Liabilities Property Plant And Equipment And Intangible Assets
DeferredTaxLiabilitiesPropertyPlantAndEquipmentAndIntangibleAssets
14100000 usd
CY2023Q4 tbi Deferred Tax Liabilities Workers Compensation
DeferredTaxLiabilitiesWorkersCompensation
192000 usd
CY2022Q4 tbi Deferred Tax Liabilities Workers Compensation
DeferredTaxLiabilitiesWorkersCompensation
347000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
36857000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
27939000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
35122000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
25374000 usd
CY2023Q4 tbi Deferred Tax Liabilities By Jurisdiction
DeferredTaxLiabilitiesByJurisdiction
300000 usd
CY2023Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
23852000 usd
CY2023Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
834000 usd
CY2023 tbi Tax Credit Carryforward Expected Expense Benefit
TaxCreditCarryforwardExpectedExpenseBenefit
23018000 usd
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
834000 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2152000 usd
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2368000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
830000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1881000 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1930000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
124000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
53000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
188000 usd
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0 usd
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
52000 usd
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
362000 usd
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1104000 usd
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
185000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
592000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
830000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1881000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
600000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
500000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14173000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
62273000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
61634000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31317000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32889000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34798000 shares
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
558000 shares
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
636000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31317000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33447000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35434000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.77
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.86
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.74
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1343000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
394000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36000 shares
CY2023 tbi Number Of Reportable Segments Aggregated From Operating Segments
NumberOfReportableSegmentsAggregatedFromOperatingSegments
1 segment
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1906243000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2254184000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2173622000 usd
CY2023 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
60491000 usd
CY2022 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
148325000 usd
CY2021 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
131757000 usd
CY2023 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
253000 usd
CY2022 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
594000 usd
CY2021 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
734000 usd
CY2023 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4117000 usd
CY2022 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2985000 usd
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2709000 usd
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9485000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
0 usd
CY2022 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
0 usd
CY2021 us-gaap Defined Benefit Plan Actual Return On Plan Assets
DefinedBenefitPlanActualReturnOnPlanAssets
2897000 usd
CY2023 us-gaap Severance Costs1
SeveranceCosts1
1342000 usd
CY2022 us-gaap Severance Costs1
SeveranceCosts1
7935000 usd
CY2021 us-gaap Severance Costs1
SeveranceCosts1
1300000 usd
CY2023 tbi Executive Leadership Transition Costs
ExecutiveLeadershipTransitionCosts
-5788000 usd
CY2022 tbi Executive Leadership Transition Costs
ExecutiveLeadershipTransitionCosts
1422000 usd
CY2021 tbi Executive Leadership Transition Costs
ExecutiveLeadershipTransitionCosts
-232000 usd
CY2023 tbi Government Subsidy Cares Act
GovernmentSubsidyCARESAct
-525000 usd
CY2022 tbi Government Subsidy Cares Act
GovernmentSubsidyCARESAct
0 usd
CY2021 tbi Government Subsidy Cares Act
GovernmentSubsidyCARESAct
4222000 usd
CY2023 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
-5503000 usd
CY2022 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
-5449000 usd
CY2021 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
-4172000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25821000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29273000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
27556000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-23850000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
72185000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
68442000 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
3205000 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
1231000 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
5408000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20645000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73416000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73850000 usd
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1906243000 usd
CY2023 tbi Sales Revenue Services Percentof Revenue
SalesRevenueServicesPercentofRevenue
1.000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2254184000 usd
CY2022 tbi Sales Revenue Services Percentof Revenue
SalesRevenueServicesPercentofRevenue
1.000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2173622000 usd
CY2021 tbi Sales Revenue Services Percentof Revenue
SalesRevenueServicesPercentofRevenue
1.000
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
34

Files In Submission

Name View Source Status
0000768899-24-000043-index-headers.html Edgar Link pending
0000768899-24-000043-index.html Edgar Link pending
0000768899-24-000043.txt Edgar Link pending
0000768899-24-000043-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image.jpg Edgar Link pending
imagea.jpg Edgar Link pending
imageb.jpg Edgar Link pending
imagec.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbi-20231231.htm Edgar Link pending
tbi-20231231.xsd Edgar Link pending
tbi-20231231_g1.jpg Edgar Link pending
tbi-20231231_g2.jpg Edgar Link pending
tbi-20231231_g3.jpg Edgar Link pending
tbi-20231231_g4.jpg Edgar Link pending
tbi-20231231_g5.jpg Edgar Link pending
tbi10k123123ex1026.htm Edgar Link pending
tbi10k123123ex1027.htm Edgar Link pending
tbi10k123123ex1028.htm Edgar Link pending
tbi10k123123ex1029.htm Edgar Link pending
tbi10k123123ex1030.htm Edgar Link pending
tbi10k123123ex1031.htm Edgar Link pending
tbi10k123123ex1032.htm Edgar Link pending
tbi10k123123ex211.htm Edgar Link pending
tbi10k123123ex231.htm Edgar Link pending
tbi10k123123ex311.htm Edgar Link pending
tbi10k123123ex312.htm Edgar Link pending
tbi10k123123ex321.htm Edgar Link pending
tbi10k123123ex41.htm Edgar Link pending
tbi10k123123ex971.htm Edgar Link pending
tbi-20231231_lab.xml Edgar Link unprocessable
tbi-20231231_pre.xml Edgar Link unprocessable
tbi-20231231_htm.xml Edgar Link completed
tbi-20231231_def.xml Edgar Link unprocessable
tbi-20231231_cal.xml Edgar Link unprocessable